To unmask these neoplasms as NEN mimickers, the testing of the key markers CD99, INI1, and S100 is necessary in cases of Ewing sarcomas, SMARCB1-deficient neoplasms, and melanomas, respectively. This evidence concerns the gene CD99 and neoplasm.